Goto

Collaborating Authors

 necrosis


Brain Tumor Recurrence vs. Radiation Necrosis Classification and Patient Survivability Prediction

Sadique, M. S., Farzana, W., Temtam, A., Lappinen, E., Vossough, A., Iftekharuddin, K. M.

arXiv.org Artificial Intelligence

GBM (Glioblastoma multiforme) is the most aggressive type of brain tumor in adults that has a short survival rate even after aggressive treatment with surgery and radiation therapy. The changes on magnetic resonance imaging (MRI) for patients with GBM after radiotherapy are indicative of either radiation-induced necrosis (RN) or recurrent brain tumor (rBT). Screening for rBT and RN at an early stage is crucial for facilitating faster treatment and better outcomes for the patients. Differentiating rBT from RN is challenging as both may present with similar radiological and clinical characteristics on MRI. Moreover, learning-based rBT versus RN classification using MRI may suffer from class imbalance due to lack of patient data. While synthetic data generation using generative models has shown promise to address class imbalance, the underlying data representation may be different in synthetic or augmented data. This study proposes computational modeling with statistically rigorous repeated random sub-sampling to balance the subset sample size for rBT and RN classification. The proposed pipeline includes multiresolution radiomic feature (MRF) extraction followed by feature selection with statistical significance testing (p<0.05). The five-fold cross validation results show the proposed model with MRF features classifies rBT from RN with an area under the curve (AUC) of 0.8920+-.055. Moreover, considering the dependence between survival time and censor time (where patients are not followed up until death), we demonstrate the feasibility of using MRF radiomic features as a non-invasive biomarker to identify patients who are at higher risk of recurrence or radiation necrosis. The cross-validated results show that the MRF model provides the best overall performance with an AUC of 0.770+-.032.


ComplexWoundDB: A Database for Automatic Complex Wound Tissue Categorization

Pereira, Talita A., Popim, Regina C., Passos, Leandro A., Pereira, Danillo R., Pereira, Clayton R., Papa, João P.

arXiv.org Artificial Intelligence

Complex wounds usually face partial or total loss of skin thickness, healing by secondary intention. They can be acute or chronic, figuring infections, ischemia and tissue necrosis, and association with systemic diseases. Research institutes around the globe report countless cases, ending up in a severe public health problem, for they involve human resources (e.g., physicians and health care professionals) and negatively impact life quality. This paper presents a new database for automatically categorizing complex wounds with five categories, i.e., non-wound area, granulation, fibrinoid tissue, and dry necrosis, hematoma. The images comprise different scenarios with complex wounds caused by pressure, vascular ulcers, diabetes, burn, and complications after surgical interventions. The dataset, called ComplexWoundDB, is unique because it figures pixel-level classifications from $27$ images obtained in the wild, i.e., images are collected at the patients' homes, labeled by four health professionals. Further experiments with distinct machine learning techniques evidence the challenges in addressing the problem of computer-aided complex wound tissue categorization. The manuscript sheds light on future directions in the area, with a detailed comparison among other databased widely used in the literature.


Predicted disease compositions of human gliomas estimated from multiparametric MRI can predict endothelial proliferation, tumor grade, and overall survival

Diller, Emily E, Cao, Sha, Ey, Beth, Lober, Robert, Parker, Jason G

arXiv.org Machine Learning

Background and Purpose: Biopsy is the main determinants of glioma clinical management, but require invasive sampling that fail to detect relevant features because of tumor heterogeneity. The purpose of this study was to evaluate the accuracy of a voxel-wise, multiparametric MRI radiomic method to predict features and develop a minimally invasive method to objectively assess neoplasms. Methods: Multiparametric MRI were registered to T1-weighted gadolinium contrast-enhanced data using a 12 degree-of-freedom affine model. The retrospectively collected MRI data included T1-weighted, T1-weighted gadolinium contrast-enhanced, T2-weighted, fluid attenuated inversion recovery, and multi-b-value diffusion-weighted acquired at 1.5T or 3.0T. Clinical experts provided voxel-wise annotations for five disease states on a subset of patients to establish a training feature vector of 611,930 observations. Then, a k-nearest-neighbor (k-NN) classifier was trained using a 25% hold-out design. The trained k-NN model was applied to 13,018,171 observations from seventeen histologically confirmed glioma patients. Linear regression tested overall survival (OS) relationship to predicted disease compositions (PDC) and diagnostic age (alpha = 0.05). Canonical discriminant analysis tested if PDC and diagnostic age could differentiate clinical, genetic, and microscopic factors (alpha = 0.05). Results: The model predicted voxel annotation class with a Dice similarity coefficient of 94.34% +/- 2.98. Linear combinations of PDCs and diagnostic age predicted OS (p = 0.008), grade (p = 0.014), and endothelia proliferation (p = 0.003); but fell short predicting gene mutations for TP53BP1 and IDH1. Conclusions: This voxel-wise, multi-parametric MRI radiomic strategy holds potential as a non-invasive decision-making aid for clinicians managing patients with glioma.